Literature DB >> 23457128

Sodium nitrite and cardioprotective effect in pig regional myocardial ischemia-reperfusion injury model.

Suat Doganci1, Vedat Yildirim, Cengiz Bolcal, Petek Korkusuz, Bulent Gumusel, Ufuk Demirkilic, Ahmet Aydin.   

Abstract

OBJECTIVES: The present study was designed to investigate the cardioprotective effect of sodium nitrite (NaNO2) and sodium nitrate (NaNO3) against myocardial ischemia-reperfusion (I/R) injury in a pig regional ischemia model.
MATERIAL AND METHODS: Eighteen pigs were randomly divided into three groups as control (Group 1), sodium nitrite (Group 2) and sodium nitrate (Group 3) groups. Before the exploration of the heart, blood samplings were taken for alanine aminotranspherase (ALT), aspartate aminotranspherase (AST), lactate dehydrogenase (LDH), creatinine kinase-muscle band (CK-MB), troponin-t, glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA) and nitrite/nitrate (NO2-/NO3-) in all groups (T0). Following sternotomy and stabilization, blood and tissue samples were repeated (T1). Then, intracoronary sodium nitrite and sodium nitrate were given (0.5µg/kg) in Groups 2 and 3. Five minutes later, the left anterior descending (LAD) artery was ligated for I/R experiments. Blood and tissue samplings were repeated after 60 minutes of ischemia (T2) and 180 minutes of reperfusion period (T3). Light and electron microscopic investigations were performed.
RESULTS: There were statistically significant results in favor of Group 2 in all studied parameters. Hemodynamic parameters showed a decrease in mean arterial pressure (MAP), cardiac output (CO), cardiac index (CI) and an increase in heart rate, mean pulmonary artery pressure (MPAP), left ventricle end-diastolic pressure (LVEDP), pulmonary capillary wedge pressure (PCWP) during ischemia. Following the ischemia these parameters returned to their near normal levels. This was prominent in group 2. Oxidative parameters showed protective increases in GPx, SOD, CAT and NO2-/NO3- levels and a decrease at MDA both in tissue and blood samples in group 2. There were statistical differences only in T3 for AST, troponin-t and CK-MB levels in favor of Group 2. Histological and electron microscopy examinations were also in favor of NO2- group.
CONCLUSIONS: The results of the present study indicate that NaNO2 provides protection against myocardial I/R injury when compared to control and NaNO3 groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23457128

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  5 in total

1.  The role of nitric oxide in regulation of leukocyte migration into the heart tissue in vitro.

Authors:  A A Petenkova; R I Kovalenko; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2016-01-05

Review 2.  Inorganic nitrite supplementation for healthy arterial aging.

Authors:  Amy L Sindler; Allison E Devan; Bradley S Fleenor; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

3.  Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).

Authors:  Nishat Siddiqi; Christopher Neil; Margaret Bruce; Graeme MacLennan; Seonaidh Cotton; Sofia Papadopoulou; Martin Feelisch; Nicholas Bunce; Pitt O Lim; David Hildick-Smith; John Horowitz; Melanie Madhani; Nicholas Boon; Dana Dawson; Juan Carlos Kaski; Michael Frenneaux
Journal:  Eur Heart J       Date:  2014-03-17       Impact factor: 29.983

4.  Sodium nitrite provides angiogenic and proliferative effects in vivo and in vitro.

Authors:  Vedat Yildirim; Suat Doganci; Fatih Yesildal; Erkan Kaya; Mehmet Emin Ince; Gokhan Ozkan; Bulent Gumusel; Ferit Avcu; Taner Ozgurtas
Journal:  Med Sci Monit Basic Res       Date:  2015-03-30

5.  Cardioprotective effects and underlying mechanism of Radix Salvia miltiorrhiza and Lignum Dalbergia odorifera in a pig chronic myocardial ischemia model.

Authors:  Rui Lin; Jialin Duan; Fei Mu; Haixu Bian; Meina Zhao; Min Zhou; Yao Li; Aidong Wen; Yong Yang; Miaomiao Xi
Journal:  Int J Mol Med       Date:  2018-08-27       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.